Cellgen Diagnostics Inc., of Irvine, Calif., and Genomic Testing Cooperative are collaborating to accelerate global development of companion tests for various oncology therapeutics, using GTC's next-generation sequencing, artificial intelligence-based biomarker discovery services and Cellgen's companion diagnostics platform. Financial terms were not disclosed.